{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:39:21Z","timestamp":1762857561446,"version":"build-2065373602"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,11]]},"DOI":"10.7759\/cureus.96544","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:36:06Z","timestamp":1762857366000},"source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune Disease Flare-Up in a Case of Locally Advanced Breast Carcinoma Controlled by Surgical Resection"],"prefix":"10.7759","author":[{"given":"Ilango","family":"Parthasarathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowtham Karthik","family":"V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed A","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson A","year":"2001","unstructured":"Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001, 345:340-50. 10.1056\/NEJM200108023450506","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-424. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.161","article-title":"Clinical implications of shared genetics and pathogenesis in autoimmune diseases","volume":"9","author":"Zhernakova A","year":"2013","unstructured":"Zhernakova A, Withoff S, Wijmenga C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol. 2013, 9:646-59. 10.1038\/nrendo.2013.161","journal-title":"Nat Rev Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2014.09.004","article-title":"Mechanism of action of immunotherapy","volume":"41 Suppl 5","author":"Disis ML","year":"2014","unstructured":"Disis ML. Mechanism of action of immunotherapy. Semin Oncol. 2014, 41 Suppl 5:S3-13. 10.1053\/j.seminoncol.2014.09.004","journal-title":"Semin Oncol"},{"key":"ref5","article-title":"Autoimmunity and cancer: paradox and opportunity","volume":"8","author":"Tan EM","year":"2008","unstructured":"Tan EM, Zouali M. Autoimmunity and cancer: paradox and opportunity. Nat Rev Cancer. 2008, 8:798-806.","journal-title":"Nat Rev Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser KE","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006, 6:24-37. 10.1038\/nrc1782","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell RB","year":"2003","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003, 349:1543-54. 10.1056\/NEJMra023009","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 expression in triple-negative breast cancer","volume":"2","author":"Mittendorf EA","year":"2014","unstructured":"Mittendorf EA, Philips AV, Meric-Bernstam F, et al.. PD-L1 expression in triple-negative breast cancer. Cancer Immunol Res. 2014, 2:361-70. 10.1158\/2326-6066.CIR-13-0127","journal-title":"Cancer Immunol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu187","article-title":"Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors","volume":"25","author":"Balma\u00f1a J","year":"2014","unstructured":"Balma\u00f1a J, Tung NM, Isakoff SJ, et al.. Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors. Ann Oncol. 2014, 25:1656-63. 10.1093\/annonc\/mdu187","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-015-0534-5","article-title":"A rare case of severe myositis as paraneoplastic syndrome on breast cancer","volume":"13","author":"Dias LP","year":"2015","unstructured":"Dias LP, Faria AL, Scandiuzzi MM, Inhaia CL, Shida JY, Gebrim LH. A rare case of severe myositis as paraneoplastic syndrome on breast cancer. World J Surg Oncol. 2015, 13:134. 10.1186\/s12957-015-0534-5","journal-title":"World J Surg Oncol"},{"key":"ref11","article-title":"Immune-mediated adverse effects of anticancer therapy","volume":"29","author":"Vial T","year":"2006","unstructured":"Vial T, Descotes J.. Immune-mediated adverse effects of anticancer therapy. Drug Saf. 2006, 29:385-98.","journal-title":"Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill CL","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, et al.. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001, 357:96-100. 10.1016\/S0140-6736(00)03540-6","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030987","article-title":"Current knowledge of the molecular pathogenesis of cutaneous lupus erythematosus","volume":"12","author":"Miyagawa F","year":"2023","unstructured":"Miyagawa F. Current knowledge of the molecular pathogenesis of cutaneous lupus erythematosus. J Clin Med. 2023, 12:987. 10.3390\/jcm12030987","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402328-autoimmune-disease-flare-up-in-a-case-of-locally-advanced-breast-carcinoma-controlled-by-surgical-resection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:36:06Z","timestamp":1762857366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402328-autoimmune-disease-flare-up-in-a-case-of-locally-advanced-breast-carcinoma-controlled-by-surgical-resection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.96544","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}